ARTICLE SUMMARY:
Inside this issue, the many ways COVID-19 is already impacting medtech: a proposed delay in EU MDR implementation, a reassessment of diagnostics regulations, changed approaches for regulatory submissions and clinical research. We cover these stories and more in the March issue of Market Pathways.